ArticlePloS one2022

Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's disease.

Marcus M Ilg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.